Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 11 studies | 27% ± 13% | |
| endothelial cell | 10 studies | 25% ± 8% | |
| fibroblast | 9 studies | 30% ± 16% | |
| microglial cell | 7 studies | 24% ± 5% | |
| adipocyte | 7 studies | 23% ± 6% | |
| myeloid cell | 6 studies | 19% ± 5% | |
| epithelial cell | 5 studies | 25% ± 4% | |
| astrocyte | 5 studies | 29% ± 9% | |
| ciliated cell | 4 studies | 19% ± 2% | |
| glutamatergic neuron | 4 studies | 39% ± 15% | |
| oligodendrocyte precursor cell | 4 studies | 21% ± 5% | |
| endothelial cell of lymphatic vessel | 4 studies | 21% ± 3% | |
| mesothelial cell | 3 studies | 20% ± 4% | |
| GABAergic neuron | 3 studies | 41% ± 5% | |
| club cell | 3 studies | 16% ± 0% | |
| monocyte | 3 studies | 20% ± 3% | |
| pericyte | 3 studies | 21% ± 7% | |
| lymphocyte | 3 studies | 18% ± 2% | |
| smooth muscle cell | 3 studies | 17% ± 3% | |
| oligodendrocyte | 3 studies | 22% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 32% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 3746.09 | 89 / 89 | 100% | 34.55 | 901 / 901 |
| liver | 100% | 4321.74 | 226 / 226 | 100% | 20.22 | 406 / 406 |
| thymus | 100% | 8888.04 | 653 / 653 | 100% | 57.94 | 605 / 605 |
| breast | 100% | 5400.10 | 459 / 459 | 100% | 48.25 | 1116 / 1118 |
| prostate | 100% | 5636.81 | 245 / 245 | 100% | 38.17 | 501 / 502 |
| lung | 100% | 4991.79 | 577 / 578 | 100% | 29.76 | 1153 / 1155 |
| uterus | 100% | 5275.93 | 170 / 170 | 100% | 28.53 | 457 / 459 |
| skin | 100% | 6372.64 | 1809 / 1809 | 99% | 26.29 | 469 / 472 |
| intestine | 100% | 4712.79 | 965 / 966 | 99% | 22.18 | 524 / 527 |
| ovary | 100% | 4817.61 | 180 / 180 | 99% | 26.78 | 427 / 430 |
| esophagus | 100% | 5436.60 | 1442 / 1445 | 99% | 19.82 | 182 / 183 |
| bladder | 100% | 3863.67 | 21 / 21 | 99% | 24.54 | 500 / 504 |
| brain | 99% | 2398.74 | 2609 / 2642 | 100% | 36.31 | 705 / 705 |
| adrenal gland | 100% | 8054.62 | 258 / 258 | 99% | 29.84 | 227 / 230 |
| stomach | 100% | 4203.95 | 358 / 359 | 99% | 22.39 | 283 / 286 |
| pancreas | 90% | 1540.90 | 295 / 328 | 99% | 40.52 | 176 / 178 |
| adipose | 100% | 6194.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 30.50 | 29 / 29 |
| spleen | 100% | 4255.42 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 28.22 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.33 | 1 / 1 |
| blood vessel | 100% | 6336.36 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 6301.43 | 802 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 30.85 | 79 / 80 |
| heart | 98% | 2974.30 | 848 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 79% | 2962.15 | 738 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0038160 | Biological process | CXCL12-activated CXCR4 signaling pathway |
| GO_0031398 | Biological process | positive regulation of protein ubiquitination |
| GO_0030097 | Biological process | hemopoiesis |
| GO_0016020 | Cellular component | membrane |
| GO_0031625 | Molecular function | ubiquitin protein ligase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | WBP1L |
| Protein name | WW domain binding protein 1-like (Outcome predictor in acute leukemia 1) WW domain binding protein 1 like |
| Synonyms | OPA1L C10orf26 |
| Description | |
| Accessions | ENST00000369889.5 [Q9NX94-1] ENST00000647664.1 ENST00000448841.7 [Q9NX94-2] Q9NX94 A0A3B3IU90 |